期刊文献+

联用鼠神经生长因子与依达拉奉治疗脑出血患者的临床效果及安全性

Clinical Effects and Safety of Combined Use of Mouse Nerve Growth Factor and Edaravone in the Treatment of Patients with Cerebral Hemorrhage
原文传递
导出
摘要 目的探讨联用鼠神经生长因子与依达拉奉治疗脑出血患者的临床效果及安全性。方法选取2019年2月至2020年2月辽阳市第二人民医院收治的124例脑出血患者作为研究对象,按治疗方式不同将其分为单一组(给予依达拉奉治疗)和联合组(在单一组的基础上联合鼠神经生长因子治疗),每组62例。比较两组治疗前、治疗半个月后的美国国立卫生研究院卒中量表(NIHSS)、日常生活活动能力量表(ADL)评分以及S100B蛋白、血清神经元特异性烯醇化酶(NSE)、髓鞘碱性蛋白(MBP)水平,并比较两组治疗后不良反应发生率。结果治疗后,联合组NIHSS评分低于单一组,而ADL评分高于单一组,差异有统计学意义(P<0.05);治疗后联合组S100B蛋白、NSE、MBP水平低于单一组,差异有统计学意义(P<0.05);联合组不良反应发生率为6.45%,低于单一组12.90%,但差异无统计学意义(P>0.05)。结论给予脑出血患者鼠神经生长因子与依达拉奉联合治疗,可有效修复患者的受损的神经,提升日常生活能力,且不良反应小,安全性好。 Objective To explore the clinical effects and safety of combined use of mouse nerve growth factor and edaravone in the treatment of patients with cerebral hemorrhage. Methods A total of 124 patients with cerebral hemorrhage admitted to the Second People’s Hospital of Liaoyang City from February 2019 to February 2020 were selected as the research objects. According to different treatment methods, they were divided into a single group(treated with Edaravone) and a combined group(treated with mouse nerve growth factor on the basis of single group), with 62 cases in each group. The NIHSS, ADL scores, S100 B protein, NSE and MBP levels were compared before and half a month after treatment, and the incidence of adverse reactions was compared between the 2 groups. Results After treatment, the NIHSS score of the combined group was lower than that of the single group, while the ADL score was higher than that of the single group, the difference was statistically significant(P<0.05);the S100 B protein, NSE, MBP levels of the combined group were lower than those of the single group, the difference was statistically significant(P<0.05);the incidence of adverse reactions in the combined group was 6.45%, lower than that in the single group(12.90%), but there was no significant difference in the results(P>0.05). Conclusion The combined treatment of mouse nerve growth factor and edaravone in patients with cerebral hemorrhage can effectively repair the damaged nerves and improve the ability of daily life, with little adverse reactions and good safety.
作者 于洋 YU Yang(The Second Department of Neurology,the Second People's Hospital of Liaoyang City,Liaoyang 111010,China)
出处 《中国药物经济学》 2021年第8期100-102,106,共4页 China Journal of Pharmaceutical Economics
关键词 鼠神经生长因子 依达拉奉 脑出血 安全性 不良反应 Mouse nerve growth factor Edaravone Intracerebral hemorrhage Safety Adverse reactions
  • 相关文献

参考文献10

二级参考文献115

  • 1闫丙川,王明科,郑春玲,龙翠英.注射用鼠神经生长因子治疗急性脑出血62例疗效观察[J].中国实用神经疾病杂志,2013,16(18):94-95. 被引量:26
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33053
  • 3脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15761
  • 4蔡业峰,贾真,李伟峰,文龙龙,张燕婷,郭建文,欧爱华,梁伟雄,裴建,黄燕,黄培新.中文版Barthel指数对多中心测评缺血性卒中患者预后的研究[J].中国脑血管病杂志,2007,4(11):486-490. 被引量:186
  • 5Behrouz R,Hafeez S,Miller C.Admission Leukocytosis in Intracerebral Hemorrhage:Associated Factors and Prognostic Implications[J].Neurocrit Care,2015,23(3):370-373.
  • 6Zhang Z,Liu Y,Huang Q,et al.Nuclear factor-κB activation in perihematomal brain tissue correlates with outcome in patients with intracerebral hemorrhage[J].J Neuroinflammation,2015,12(1):277.
  • 7Camacho E,LoPresti M,Bruce S,et al.The role of age in intracerebral hemorrhages[J].J Clin Neurosci,2015,22(12):1867-1870.
  • 8Chen J,Qin J,Su Q,et al.Treadmill rehabilitation treatment enhanced BDNF-TrkB but not NGF-TrkA signaling in a mouse intracerebral hemorrhage model[J].Neurosci Lett,2012,529(1):28-32.
  • 9Solev I,Balabanyan V,Volchek I,et al.Involvement of BDNF and NGF in the mechanism of neuroprotective effect of human recombinant erythropoietin nanoforms[J].Bull Exp Biol Med,2013,155(2):242-244.
  • 10Kurz H,Prammer R,Bock W,et al.Intracranial hemorrhage and other symptoms in infants associated with human parechovirus in Vienna,Austria[J].Eur J Pediatr,2015,174(12):1639-1647.

共引文献180

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部